[1] |
ZHANG Meiwei, LI Keqian, YAO Keyu, ZHU Yan.
Current Descriptions of Functions in Package Inserts of Chinese Herbal Patent Medicines
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 193-196.
|
[2] |
YANG Le, SHAN Lianlian, WANG Yali, YAN Shunhua, ZHOU Gang, CHEN Jia, WEI Feng.
Quality standard for licorice of different sources
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 1025-1028.
|
[3] |
ZHU Yan, LI Qingna, ZHU Lan, XIE Jiang’an, YAO Keyu, HUANG Guangrui, YANG Xiaolin, GUAN Jian.
Current situation and suggestions concerning the implementation of MedDRA in drug monitoring in China
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 746-751.
|
[4] |
DING Xiaoli, HU Xinyue, WANG Xuelei, SUN Yue, LI Jing, ZHANG Hui, Liang Chenggang, WANG Yan.
Quality evaluation of insulin glargine injections
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 644-650.
|
[5] |
JIA Yinyin, ZHANG Caishu, ZHOU Ying, LIU Li, GENG Ying, WEI Ningyi, NIU Sijing, CHEN Hua, XU Hui.
Evaluation methods for aerodynamic particle size distribution of fine particles in inhaled products
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 141-146.
|
[6] |
ZHANG Jian, FANG Huihua.
Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189.
|
[7] |
LI Yaolei, JIN Hongyu, WEI Feng, MA Shuangcheng.
Introduction and Quality Factors of Peucedanum Praeruptorum Dunn
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1315-1320.
|
[8] |
WANG Xiang, SUN Shuai, WANG Xinguo, NIU Liying.
Quantitative transfer relationships of Rubia yunnanensis Diels formula granules based on standard decoctions
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 891-898.
|
[9] |
LI Ning, JIANG Xiaoya, ZHANG Zezhao, GAO Le, WANG Xinguo, LIU Xiaoming.
Preparation and quality evaluation of standard decoctions of Rosa chinensis Jacq.
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 397-402.
|
[10] |
LIU Bo, GUO Yunxiao, ZHANG Tong, HUANG Lu, HE Lanying, FAN Huihong.
A national reference standard for fructosazine and deoxyfructosazine
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 282-285.
|
[11] |
PEI Yusheng, CHEN Chen, NING Xiao, CAI Tong.
Establishment and application of the first batch of national standards for bacterial endotoxin for monocyte activation reaction tests
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1217-1220.
|
[12] |
ZHONG Yingying, WANG Zhao, ZUO Tiantian, LI Yaolei, LI Hailiang, MA Shuangcheng.
Research progress on detection and risk assessment of exogenous heavy metals and related elements in Codonopsis Radix
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1309-1315.
|
[13] |
XIONG Jing, LIU Yi, LIU Zhaoxia, LI Jie, ZHANG Caiyu, WU Xiangxiang, HE Lan.
Development of the first national reference substance of ritonavir as a candidate drug against COVID-19
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 137-141.
|
[14] |
WANG Meng, ZHI Yajing, QIE Lanxia, GUO Jiahui, CAI Yuluo, NIU Liying.
Yi medicine Micromeria biflora (Buch.Ham.ex D.Don)Benth. standard decoction
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(12): 1315-1320.
|
[15] |
WANG Yue, SONG Yujuan, LIU Qian, ZHAO Xiangmei, DENG Lijuan, FAN Huihong.
Quality evaluation and quality research of domestic hydroxyethyl starch 130/0.4 injection
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(10): 1067-1072.
|